Physician profile
Elisa Rogowitz
NPI 1407268360
$1,522.71
in general payments reported to CMS, 2019-2025
10 companies · $51.06 in 2025
The $51.06 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2021: $404 · 2022: $408 · 2023: $67.68 · 2024: $295 · 2025: $51.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $811.69 | 2021-2022 | |
| Beta Bionics, INC. | $213.12 | 2023-2024 | Ilet Bionic Pancreas |
| Neurocrine Biosciences, INC. | $200.00 | 2019 | |
| Medtronic Minimed, INC. | $97.39 | 2019 | |
| Tandem Diabetes Care, INC. | $74.02 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astellas Pharma US INC | $33.12 | 2024 | Veozah |
| Lilly USA, LLC | $31.18 | 2023-2024 | Mounjaro, Trulicity, Zepbound |
| Cequr Corporation | $23.67 | 2023 | Cequr Simplicity |
| Ascendis Pharma Endocrinology INC | $22.12 | 2025 | Yorvipath |
| Mannkind Corporation | $16.40 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elisa Rogowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.